Skip to main content

Table 1 Baseline characteristics and disease status of patients

From: A mutation in the interferon regulatory element of HBV may influence the response of interferon treatment in chronic hepatitis B patients

 

Response

Non-response

Patients, n

40

22

Age, years(mean ± SD)

28.9 ± 11.0

28.0 ± 8.3

Sex, male(no.,%)

34(85.0)

17(77.3)

Pathogenesis, days(mean ± SD)

1719.5 ± 1168.0

1503.8 ± 1322.1

Family history(no.,%)

7(17.5)

2(9.0)

HBV DNA, log copies/ml(mean ± SD)

5.1 ± 0.9

5.4 ± 1.0

ALT, IU/L(mean ± SD)

260.9 ± 84.0

248.1 ± 112.0